Skip to main content

Dr. Christopher Brückner

German Patent Attorney (Patentanwalt)

European Patent, Trademark and Design Attorney

 

Many IP-experts in the pharmaceutical industry know Dr. Brückner as the author of the German-English commentary on Supplementary Protection Certificates (SPCs). His combined qualifications as patent attorney and pharmacist, in combination with his corporate in-house experience, make him a sought-after contact for legal and entrepreneurial issues.

His articles are published in law journals, and he is frequently invited to speak on this topic. He is also a co-author of the Singer / Stauder commentary on the European Patent Convention.

Before joining Dennemeyer, Dr. Christopher Brückner was employed in the patent department of an internationally-known German company and after that in two patent law firms. 

In 2012, the Higher Regional Court of Düsseldorf selected Dr. Brückner as a court-appointed expert. In 2016, the Max Planck Institute for Innovation and Competition requested that Dr. Brückner participates in the preparation of a study commissioned by the EU. The purpose of the study was to assess whether the current EU Regulation 469/2009 for SPCs meets today’s technical and legal requirements. 

Dr. Christopher Brückner speaks English and German and has been active in the field of IP since 2001.

Area of expertise: Chemistry, Pharmaceuticals, Patents

Qualifications et certifications

  • Patentanwalt
  • European Patent, Trademark and Design Attorney
  • Dr. rer. nat. (Pharmacy, Germany)
  • Approbated Pharmacist (Germany)

Récompenses et affiliations

  • VPP
  • FICPI
  • EPI
  • EPLIT
  • PLCD
  • DPhG (German Pharmaceutical Association) and Richard-Wagner-Verband (Richard Wagner Association).

 

Sélection de publications

  • "Ergänzende Schutzzertifikate / Supplementary Protection Certificates", Carl Heymanns Verlag, 2nd edition, 2013
  • "Europäisches Patentübereinkommen, EPÜ: Heymanns Taschenkommentar", 7th edition, 2015
  • Christopher Brückner, Peter von Czettritz "Laufzeitverlängerung eines SPC aufgrund fremder paritätischer Studien?" MittdtPatA 2012, 256
  • Christopher Brückner, Rudolf Teschemacher "Gerichtshof der Europäischen Union: Patentrecht", GRURInt 2012, 523
  • Christopher Brückner "Patent- und zulassungsrechtliche Voraussetzungen der Erteilung ergänzender Schutzzertifikate für Arzneimittel - Zugleich Anmerkung zu EuGH", Urteil vom 24. November 2011, Rs. C-322/10 (Medeva B.V. ./. Comptroller General of Patents, Designs and Trademarks), GRURInt 2012, 300